Delving into maxillofacial pathology, Malignant Salivary Gland Tumors stand out as a challenging yet critical area of study. These rare tumors can affect both major and minor salivary glands, presenting diverse forms such as adenoid cystic carcinoma and mucoepidermoid carcinoma. Recognizing symptoms like swelling, pain, or numbness in the affected area is key, prompting timely medical attention. Early diagnosis is pivotal for effective management, often involving surgical removal followed by radiation therapy. The complexity of these tumors necessitates a multidisciplinary approach, with collaboration between oncologists, surgeons, and pathologists. By fostering awareness of symptoms and promoting swift medical intervention, we contribute to improved prognoses and outcomes for individuals grappling with malignant salivary gland tumors.
Introduction: Low-grade polymorphous adenocarcinoma is a malignant neoplasm of salivary glands with uncommon occurrence in the head and neck region. The lesions occur more frequently among elderly…
Introduction: Low-grade polymorphous adenocarcinoma is a malignant neoplasm of salivary glands with uncommon occurrence in the head and neck region. The lesions occur more frequently among elderly…
Introduction: Temporomandibular disease (TMD) is a common yet not fully understood condition. Many patients with TMD present to oral and maxillofacial clinics, however it is important to have a…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Malignant Salivary Gland Tumors work, reviewed by the scientific committee.
Meet dentists, oral-health researchers, and clinical leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Malignant Salivary Gland Tumors research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Malignant Salivary Gland Tumors track is a dedicated stream within Dental 2027 covering the latest research, clinical innovation, and best practice in Malignant Salivary Gland Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Educators, doctoral students, and dentists, oral-health researchers, and clinical leaders with an interest in Malignant Salivary Gland Tumors are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. Dental 2027 is a hybrid conference — attend the Malignant Salivary Gland Tumors track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
Register